Gene307
ANXA4: annexin A4
13 sourcesgene-search-2026-11-13-0.2.1
Cite this record
ConductScience Library. ANXA4: annexin A4. Genes, record 307. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/307
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P09525 | Annexin A4 | 319 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents54
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260196299 A1 | 2026-07-09 | 290 | P09525 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 40380 | P09525 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 40380 | P09525 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 40380 | P09525 | Espacenet |
| US 20250135002 A1 | 2025-05-01 | 23 | P09525 | Espacenet |
| US 20250136689 A1 | 2025-05-01 | 5 | P09525 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 26009 | P09525 | Espacenet |
| US 11378580 B2 | 2022-07-05 | 1 | P09525 | Espacenet |
| US 11378580 B2 | 2022-07-05 | 1 | P09525 | Espacenet |
| EP 3647788 A1 | 2020-05-06 | 3 | P09525 | Espacenet |
NIH grants787
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ANXA4 papers | Newest fiscal year |
|---|---|---|---|
| P30CA006973 | Regional Oncology Research Center | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| P20GM113226 | Hepatobiology and Toxicology COBRE | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 2 | 2025 |
| P30CA118100 | University of New Mexico Cancer Center Support Grant | 2 | 2025 |
| P30DK034854 | Integrated Epithelial and Muscosal Biology | 2 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 2 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 2 | 2025 |
Source NIH's project files
Papers1,165
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Annexin A4 Deficient Ventricular Myocytes Display Advanced Hypertrophy and Electrical Remodeling With Chronic β-Adrenoceptor Stimulation. | FASEB J | 2026 | 42684683 | PubTator, text mining | PubMed |
| DNA demethylation of ANXA4 is associated with atrial fibrillation risk through myeloid immune mechanisms: evidence from Mendelian randomization and multi-omics analyses. | Clin Epigenetics | 2026 | 42185861 | PubTator, text mining | PubMed |
| Identification of core genes mediating the association between obesity and hepatocellular carcinoma: A bioinformatics study based on mitochondrial metabolism and immune pathways. | PLoS One | 2026 | 41801960 | PubTator, text mining | PubMed |
| A Thiadiazolopyrimidinone-Based Molecule Targeting Annexin A6 Impairs Cell Motility and Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells Lacking Annexin A1. | Cells | 2026 | 41744829 | PubTator, text mining | PubMed |
| DNA methylation signatures associated with early-onset schizophrenia in Chinese patients. | Transl Psychiatry | 2026 | 41667419 | PubTator, text mining | PubMed |
| Exploring rare coding variants in UK biobank: preliminary associations with motor neuron disease. | Front Aging Neurosci | 2025 | 41583004 | PubTator, text mining | PubMed |
| Integrated Proteogenomic Approach for Discovering Potential Biomarkers in Urothelial Carcinoma of the Bladder. | Biomedicines | 2025 | 41463032 | PubTator, text mining | PubMed |
| Overlooked environmental risks of type 2 diabetes: Evidence from a case-control study on the roles of dechlorane plus (DPs) and novel brominated flame retardants (NBFRs). | Ecotoxicol Environ Saf | 2025 | 41308354 | PubTator, text mining | PubMed |
| Targeting ANXA4 to Overcome Cisplatin Resistance in Ovarian Cancer: A Bioinformatics and in Vitro Study. | Onco Targets Ther | 2025 | 41230108 | PubTator, text mining | PubMed |
| Epigenetic modifications of immune cells in rheumatoid arthritis. | Ann Med | 2025 | 40990388 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/307
GET https://conductscience.org/api/genes/v1/307/patents?page=2